Literature DB >> 19345328

Oncogenic Braf induces melanocyte senescence and melanoma in mice.

Nathalie Dhomen1, Jorge S Reis-Filho, Silvy da Rocha Dias, Robert Hayward, Kay Savage, Veronique Delmas, Lionel Larue, Catrin Pritchard, Richard Marais.   

Abstract

We show here that inducible expression of Braf(V600E) off the endogenous Braf gene in mouse melanocytes stimulates skin hyperpigmentation and the appearance of nevi harboring senescent melanocytes. Additionally, approximately 70% of Braf(V600E) mice develop melanomas that reproduce many of the cardinal histological and molecular features of human melanoma and whose cells can colonize the lungs of nude mice. We show that the tumor suppressor p16(INK4a) is not required to induce melanocyte senescence and that its loss is not required for tumor progression, although it does regulate tumor penetrance and latency. Thus, we have developed a mouse model of melanoma driven by Braf(V600E) expressed at physiological levels that reflects the genetics and pathology of the human disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345328     DOI: 10.1016/j.ccr.2009.02.022

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  258 in total

Review 1.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

Review 2.  Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.

Authors:  Gajanan S Inamdar; SubbaRao V Madhunapantula; Gavin P Robertson
Journal:  Biochem Pharmacol       Date:  2010-05-09       Impact factor: 5.858

3.  Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability.

Authors:  Katrine B V Greve; Jonas N Lindgreen; Mikkel G Terp; Christina B Pedersen; Steffen Schmidt; Jan Mollenhauer; Stine B Kristensen; Rikke S Andersen; Mette M Relster; Henrik J Ditzel; Morten F Gjerstorff
Journal:  Mol Oncol       Date:  2014-10-06       Impact factor: 6.603

4.  Pirin inhibits cellular senescence in melanocytic cells.

Authors:  Silvia Licciulli; Chiara Luise; Gaia Scafetta; Maria Capra; Giuseppina Giardina; Paolo Nuciforo; Silvano Bosari; Giuseppe Viale; Giovanni Mazzarol; Chiara Tonelli; Luisa Lanfrancone; Myriam Alcalay
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 5.  From genes to drugs: targeted strategies for melanoma.

Authors:  Keith T Flaherty; F Stephen Hodi; David E Fisher
Journal:  Nat Rev Cancer       Date:  2012-04-05       Impact factor: 60.716

Review 6.  Pathways of oncogene-induced senescence in human melanocytic cells.

Authors:  Rajat Bansal; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

Review 7.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

8.  Are oncogenes sufficient to cause human cancer?

Authors:  Scott E Woodman; Gordon B Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-17       Impact factor: 11.205

Review 9.  Genetics of metastasis: melanoma and other cancers.

Authors:  Noel Turner; Olivia Ware; Marcus Bosenberg
Journal:  Clin Exp Metastasis       Date:  2018-05-02       Impact factor: 5.150

10.  Is reliance on mitochondrial respiration a "chink in the armor" of therapy-resistant cancer?

Authors:  Dieter A Wolf
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.